Michelle Hoffmann, Ph.D. has been the Executive Director of the Chicago Biomedical Consortium (CBC), since 2021. The CBC is a consortium of biomedical researchers across Northwestern, the University of Illinois at Chicago, and the University of Chicago that is generously supported by the Searle Funds at The Chicago Community Trust. The CBC’s mission is to stimulate collaboration among scientists to accelerate discovery that will transform biomedical research and improve the health of humankind. In her time as Executive Director, Dr. Hoffmann has reorganized the CBC to train local PhD talent in early science commercialization while finding and funding the most promising biopharma applications of Chicago university science. Prior to this role, from 2019-2021, Dr. Hoffmann was the Senior Vice President of Deep Tech at P33, a privately funded nonprofit charged with inclusively elevating Chicagoland’s innovation economy. Hoffmann spent 15 years helping life sciences companies grow, most recently as SVP at Boston-based Back Bay Life Science Advisors. During her time at Back Bay, Hoffmann led projects for large, publicly traded and venture-backed life sciences companies. Hoffmann earned a PhD in molecular and cellular biology from the University of California Berkeley and completed a postdoctoral fellowship at Brandeis University.